# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016509
Filing Date
2022-04-28
Accepted
2022-04-28 17:04:06
Documents
9
Period of Report
2022-06-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | eldn-def14a_20220621.htm | DEF 14A | 783905
2 | GRAPHIC | gaamciq2zk44000002.jpg | GRAPHIC | 7227
3 | GRAPHIC | gaamciq2zk44000004.jpg | GRAPHIC | 1611
4 | GRAPHIC | gaamciq2zk44000005.jpg | GRAPHIC | 2961
5 | GRAPHIC | gaamciq2zk44000003.jpg | GRAPHIC | 2946
6 | GRAPHIC | gaamciq2zk44000001.jpg | GRAPHIC | 12973
7 | GRAPHIC | gaamciq2zk44000008.jpg | GRAPHIC | 592058
8 | GRAPHIC | gaamciq2zk44000006.jpg | GRAPHIC | 3818
9 | GRAPHIC | gaamciq2zk44000007.jpg | GRAPHIC | 4399
| Complete submission text file | 0001564590-22-016509.txt |  | 1650976

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 22867854
SIC: 2834 Pharmaceutical Preparations